Verano Holdings (VRNO) Asset Utilization Ratio (2022 - 2026)
Verano Holdings' (VRNO) quarterly Asset Utilization Ratio came in at 0.48 in Q1 2026, up 8.62% year-on-year from 0.44 in Q1 2025, and up 6.08% on a QoQ basis from 0.45 in Q4 2025.
Verano Holdings (VRNO) Asset Utilization Ratio (2022 - 2026) Analysis & Trends
Verano Holdings (VRNO) has 5 years of Asset Utilization Ratio data on file, last reported at 0.48 in Q1 2026.
- On a quarterly basis, Asset Utilization Ratio rose 8.62% year-over-year to 0.48 in Q1 2026; TTM through Mar 2026 was 0.48, a 8.62% increase from a year earlier, with the FY2025 full-year figure at 0.44, up 7.95% from the prior year.
- Asset Utilization Ratio for Q1 2026 stood at 0.48, up from 0.45 in the prior quarter.
- Over the last five years, Asset Utilization Ratio for VRNO reached as high as 0.48 in Q1 2026 and fell as low as 0.3 in Q3 2024.
- Historically, Asset Utilization Ratio has averaged 0.38 across 5 years, with a median of 0.39 in 2023.
- Across the five-year window, Asset Utilization Ratio slipped 24.59% in 2024 and jumped 46.67% in 2025, its largest moves.
- Year by year, Asset Utilization Ratio stood at 0.35 in 2022, then climbed by 14.6% to 0.4 in 2023, then decreased by 23.93% to 0.31 in 2024, then soared by 46.67% to 0.45 in 2025, then increased by 6.08% to 0.48 in 2026.
- Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.48 in Q1 2026, 0.45 in Q4 2025, and 0.43 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 0.43 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 0.62 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 0.46 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.43 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 0.39 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.65 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 0.37 |
| 10 | Verano Holdings | 2.02 Bn | 1.94 Bn | 98.98 Mn | 0.48 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.48 |
| Dec 31, 2025 | 0.45 |
| Sep 30, 2025 | 0.43 |
| Jun 30, 2025 | 0.43 |
| Mar 31, 2025 | 0.44 |
| Dec 31, 2024 | 0.31 |
| Sep 30, 2024 | 0.30 |
| Jun 30, 2024 | 0.31 |
| Mar 31, 2024 | 0.31 |
| Dec 31, 2023 | 0.40 |
| Sep 30, 2023 | 0.39 |
| Jun 30, 2023 | 0.39 |
| Mar 31, 2023 | 0.38 |
| Dec 31, 2022 | 0.35 |
| Sep 30, 2022 | 0.33 |